Montana’s SB535 and a Potential Biotech Renaissance in America
-
In 2024, China’s NMPA approved 83 new drugs, the FDA approved 50. China’s
share of new commercial clinical trials jumped from 8% globally in 2013 to
30% ...
10 hours ago
No comments:
Post a Comment